Latest News about CRSP
Recent news which mentions CRSP
Do CRISPR Therapeutics and Intellia Face a Big Safety Risk?
November 21, 2021
From Motley Fool
Better Buy: Vertex Pharmaceuticals vs. CRISPR
November 20, 2021
From Motley Fool
2 Beaten-Down Growth Stocks You Can Buy Right Now
November 17, 2021
From Motley Fool
Being First Is Not Enough For Crispr Therapeutics
November 15, 2021
From InvestorPlace
The Key Behind Vertex's Great Q3 Results
November 11, 2021
From Motley Fool
Cathie Wood's Buying Beam Therapeutics -- Should You?
November 09, 2021
From Motley Fool
Can Vertex Make Billions With a New Game-Changing Treatment? The Answer May Be Just Ahead
November 05, 2021
From Motley Fool
Why CRISPR Therapeutics Stock Fell 18.4% in October
November 04, 2021
From Motley Fool
Why Vertex Is Striking Another Gene-Editing Deal With a Company Not Named CRISPR Therapeutics
November 04, 2021
From Motley Fool
3 No-Brainer Biotech Stocks to Buy in November
November 04, 2021
From Motley Fool
5 Biotech Stocks With 105% to 386% Upside, According to Wall Street
November 03, 2021
From Motley Fool
Could This Drug Become Vertex Pharmaceuticals' Next Blockbuster?
November 02, 2021
From Motley Fool
3 Stocks Cathie Wood Is Buying That You Might Want to Consider Too
October 26, 2021
From Motley Fool
Biotech Buyouts That Would Be Great for Investors
October 22, 2021
From Motley Fool
3 of the Best Stocks to Buy Now With $500
October 22, 2021
From Motley Fool
3 Things About CRISPR Therapeutics That Smart Investors Know
October 20, 2021
From Motley Fool
If You Invested $5,000 in Vertex Pharmaceuticals In 2016, This Is How Much You Would Have Today
October 19, 2021
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2021
October 19, 2021
From Benzinga
From Motley Fool
2 Tricks and a Treat for Gene Therapy Investors
October 18, 2021
From Motley Fool
2 Gene-Editing Stocks to Have on Your Radar Right Now
October 17, 2021
From Motley Fool
2 Top Healthcare Stocks That Could Be Bought Out in 2022
October 16, 2021
From Motley Fool
If You Invested $3,000 in CRISPR Therapeutics in 2018, This Is How Much You Would Have Today
October 16, 2021
From Motley Fool
3 No-Brainer Biotech Stocks to Buy Right Now
October 16, 2021
From Motley Fool
BZ Chart Of The Day: Is Crisper Therapeutics About To Rally?
October 15, 2021
Tickers
CRSP
From Benzinga
Why Shares of Allogene Therapeutics, Beam Therapeutics, Intellia Therapeutics, and Schrödinger Are Volatile This Week
October 15, 2021
From Motley Fool
3 Highly Profitable Stocks Wall Street Thinks Will Soar 39% or More
October 15, 2021
From Motley Fool
From Benzinga
50 Biggest Movers From Yesterday
October 14, 2021
From Benzinga
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.